Skip to:
-

ACRF Cancer Biology and Stem Cells

Our division is focused on breast, lung, ovarian and rare cancers.

Sections on this page

Leadership

Laboratory Head
Laboratory Head
Division Head
Laboratory Head
Laboratory Head
Division Head

About

We are working to understand normal organ development and the problems in this process that give rise to cancer, with a view to discovering new therapies.

We have also established an extensive bank of patient-derived cancer samples for preclinical studies. These enable us to explore new treatments, study how cancer cells respond to drugs, and understand why drug resistance occurs.

Division news

Study pinpoints breast cancer ‘cells-of-origin’ in high-risk women 
17 January 2024
WEHI discovery leads to clinical trial for rare women’s cancers 
21 September 2023
Study shows benefit of universal genetic testing after breast cancer diagnosis
04 May 2023
Mapping the ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
30 June 2022
Revolutionary 3D imaging maps how breast cancer spreads
13 December 2021
New cellular atlas maps out healthy and cancerous breast tissue
14 May 2021
View all news
Diseases
© WEHI 2026
Close